AbbVie (NYSE:ABBV) and Calico, a life sciences company funded by Alphabet(NASDAQ:GOOG) (NASDAQ:GOOGL), recently announced a three-year extension of their collaboration to develop therapies for age-related diseases, including cancer and neurodegenerative disorders. The two companies first teamed up in 2014.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,